DUVELISIB for B-cell lymphoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 87 adverse event reports in the FDA FAERS database where DUVELISIB was used for B-cell lymphoma.
Most Reported Side Effects for DUVELISIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Product use in unapproved indication | 162 | 21.4% | 32 | 54 |
| Diarrhoea | 110 | 14.5% | 8 | 47 |
| Death | 89 | 11.8% | 87 | 13 |
| Fatigue | 75 | 9.9% | 5 | 24 |
| Prescribed underdose | 63 | 8.3% | 8 | 18 |
| Off label use | 57 | 7.5% | 4 | 8 |
| Nausea | 49 | 6.5% | 6 | 20 |
| Pneumonia | 40 | 5.3% | 15 | 27 |
| Pyrexia | 40 | 5.3% | 3 | 21 |
| Malignant neoplasm progression | 38 | 5.0% | 15 | 20 |
| Rash | 33 | 4.4% | 2 | 8 |
| Hospitalisation | 32 | 4.2% | 4 | 30 |
| Asthenia | 30 | 4.0% | 1 | 13 |
| Vomiting | 30 | 4.0% | 5 | 20 |
| Disease progression | 28 | 3.7% | 15 | 11 |
Other Indications for DUVELISIB
Chronic lymphocytic leukaemia (156)
Peripheral t-cell lymphoma unspecified (111)
Non-hodgkin's lymphoma (59)
Angioimmunoblastic t-cell lymphoma (54)
Product used for unknown indication (38)
Cutaneous t-cell lymphoma (37)
Follicular lymphoma (28)
T-cell lymphoma (18)
Lymphocytic leukaemia (14)
B-cell small lymphocytic lymphoma (12)
Other Drugs Used for B-cell lymphoma
RITUXIMAB (7,811)
CYCLOPHOSPHAMIDE (4,766)
VINCRISTINE (4,346)
DOXORUBICIN (3,947)
LENALIDOMIDE (3,474)
PREDNISONE (2,561)
BENDAMUSTINE (1,668)
PREDNISOLONE (1,489)
ETOPOSIDE (1,268)
IDELALISIB (1,240)